1010002807 A study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease using a Reduced-Intensity preparatory regime with Campath-1H Fludarabine and Melphalan



Study Overview

The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.


Study Description

The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.

Additional Information:

Participants will not be paid for their participation.



Research Study Identifier: TX782
ClinicalTrials.gov Identifier: NCT1010002807


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.